back top
Termis Survey: 2014 cellular and engineered tissue therapies in Europe

1300 members from 70 countries Join ICRS

Termis Survey: 2014 cellular and engineered tissue therapies in Europe

20/10/2015

We continue to collect data to establish a comprehensive, quantitative map of patients being treated in Europe with cellular and engineered tissue therapies (i.e. any clinical treatment based on living cells excluding DLI, donor lymphocyte infusions, and hematopoietic stem cells for hematological reconstitution). The survey is supported by the 6 international organisations shown above and integrates the original EBMT activity survey capturing hematopoietic stem cells transplants in Europe.

Previous survey reports which include the number of treated patients, without any reference to clinical outcomes, information on specific cell types, processes and delivery modes in use as well as an appendix listing active teams together with the survey form and guidelines can be found on the TERMIS website, http://www.termis.org/chapters_eu_novel.php

If, in 2014, you treated patients in Europe with cellular or engineered tissue therapies and would like to see your name listed among the participating teams (145 groups in 2013), please complete the survey form (on the TERMIS website at the link above) and send it by November 15th 2015 to Helen Baldomero in the Activity Survey Office, either by Email: Helen.baldomero@usb.ch or by fax: + 41 61 265 2735.

If you know of any group that is performing such therapies please forward this message to them and encourage them to participate. This will help to bring an effective impact on the scientific, clinical and regulatory aspects of the quickly evolving sector of cellular and engineered tissue therapies.

Thank you and with our best regards

Prof. Ivan Martin PhD
Depts. of Surgery and Biomedicine
University Hospital Basel, CH

and
Prof. Jakob R Passweg MD
Chief Hematology Clinic and
EBMT Transplant Activity Survey Office
University Hospital Basel, CH